HIF1A and myocardial infarction: Therefore, the HIF-1α gene could be worth consideration as a target in the prosurvival approaches for MSC therapies, since beneficial results were seen in HIF-1α-engineered MSCs in trials with a mouse hind-limb ischemia model [74] and in a rat myocardial infarction model [75].